Category - Executive Moves

Executive Moves

BioSig names Samuel Navarro to board

BioSig Technologies (NASDAQ:BSGM) appointed Samuel Navarro as an independent director.

June 25, 2019

Executive Moves

Arcus Biosciences names Eric Hoefer as chief commercial officer

Arcus Biosciences (NYSE:RCUS) appointed Eric Hoefer as its chief commercial officer to oversee the company’s global commercial strategy and operations.

June 24, 2019

Executive Moves

Raymond James names Andrew Gitkin as co-head of health care investment banking

Raymond James named finance professional, Andrew Gitkin, as managing director and co-head of the firm’s health care investment banking practice, along side managing director, Riley Sweat.

June 7, 2019

Executive Moves

Canopy Growth’s medical division names Dr. Marcel Bonn-Miller as global clinical scientific director

Spectrum Therapeutics, the medical division of Canopy Growth (TSX:WEED; NYSE:CGC) appointed Dr. Marcel Bonn-Miller as global clinical scientific director.

June 5, 2019

Executive Moves

Canopy Growth names Mike Lee as acting CFO

Canopy Growth (TSX:WEED; NYSE:CGC) appointed Mike Lee as acting CFO, effective June 1, and subject to Health Canada security clearance required for all officers and directors of the company.

May 21, 2019

Executive Moves

Zenabis provides operational update; appoints Natascha Kiernan to board

Zenabis Global (TSXV:ZENA) provide an update on its recent cannabis production figures, anticipated future harvests, facility construction and licensing status, and medical program update.

May 21, 2019

Executive Moves

Neptune Wellness names Martin Landry as chief of corporate development and strategy

Neptune Wellness Solutions (NASDAQ:NEPT; TSX:NEPT) appointed Martin Landry to the new position of chief of corporate development and strategy, effective May 27.

May 14, 2019

Executive Moves

IntelGenx names André Godin to additional post of president

IntelGenx Technologies (TSXV:IGX; OTCQX:IGXT) appointed André Godin to the additional position of president. He continues as CFO and will continue to report to CEO, Dr. Horst Zerbe.

May 9, 2019

Executive Moves

MediPharm names Braden Fenske as chief strategy officer, Dr. Paul Tam as director

MediPharm Labs (TSXV:LABS; OTCQB:MEDIF) appointed Braden Fenske as chief strategy officer and Dr. Paul Tam to its board of directors, effective immediately.

May 1, 2019

Executive Moves

Imagin Medical adds world-renowned bladder cancer expert Dr. Ashish Kamat to SAB

Imagin Medical (CSE:IME; OTCQB:IMEXF; Frankfurt & Stuttgart Symbol:DPD2) named Dr. Ashish Kamat to its scientific advisory board.

April 17, 2019

Category - Executive Moves

Subscribe